Eating Disorders in Males

In women, food intake decreases throughout the follicular phase of the menstrual cycle and is lowest during periovulation when estradiol concentrations are at their highest 13–16. It is the principal male sex hormone and the male body produces up to eight-times more buy testosterone cream than the female body . Second, the authors provide an overview of the role of reproductive hormones in eating behavior in general (Box 1). The authors begin by providing readers with a brief summary of eating disorders and the menstrual cycle.
Notably, women with AN often exhibit estradiol concentrations similar to those observed in menopausal women, 139.196.177.200 suggesting that this decrease in estradiol may hinder the effectiveness of SSRI treatments. Compared with other psychiatric disorders, the knowledge about beneficial pharmacological treatments for eating disorders is minimal. Third, exogenous administration of reproductive hormones may have important implications for eating disorder treatment and the chronicity often observed in these disorders. In order to fully characterize the role of reproductive hormones in eating disorder vulnerability and maintenance, researchers examining animal populations and researchers examining human populations will need to work closely together. Furthermore, limited work suggests that eating disorder symptoms affect the normal functioning of the estrogen system such that increased consumption of binge-type fatty meals decreases the inhibitory effect of estradiol.
Thus, future research should include attention to potential differences in risk and ED presentation in males, intersected with cultural and ethnic identification. For instance, males may be motivated to pursue rigid eating or exercise routines, as well as the use of appearance-enhancing or performance-enhancing drugs (eg, anabolic steroids) to achieve a muscular body idea. Bulimia nervosa is characterized by recurrent episodes of binge eating, the use of 1 or more compensatory strategies intended to offset the impact of binge episodes, and overvaluation of weight and shape.19 Lifetime prevalence estimates for BN among males range between 0.1% and 1.6%4,8,20,21 with males comprising approximately one-third of all BN cases in the general population.4,25 Compared with adult samples with BN, there is little empirical evidence of the adolescent experience of BN, and even less so among males. Along with the paucity of empirical research devoted solely to male populations, many full-scale clinical trials continue to exclude male patients on the premise of their assumed atypicality.14 Although many symptoms of ED among males may indeed be qualitatively different than for females, gold standard assessments for EDs demonstrate a lack of sensitivity in detecting and qualifying ED symptoms in males.15,16 Many EDs in males may be undetected, or at least indexed with symptoms that appear less in number or in severity. Currently, findings are most robust for git.smart-tool.jp the impact of estradiol on binge eating, indicating an ideal starting point from which to initiate this work. In line with this hypothesis, examining a continuous measure of disordered eating across the lifespan showed that eating disorder symptoms decrease after age 24 years. Consistent with what has been observed during puberty and pregnancy, the menopause transition may be an additional vulnerability period for eating disorder symptoms.
If the dysregulation in estradiol often observed in eating disorders, especially AN, is decreasing the efficacy of our standard treatment approaches, this would help to explain the chronic course and high frequency of relapse often observed. One hypothesis for this is that the hormonal dysregulation often observed in women with eating disorders influences the efficacy of psychotropic treatments. The underlying individual differences in the sensitivity to hormonal fluctuations may increase vulnerability to eating disorder symptoms, while engaging in the eating disorder symptoms themselves (i.e., binge eating) also serves to maintain the eating disorder. First, the absolute concentrations of these hormones may directly influence eating disorder symptoms. There are two main possibilities in which estradiol and progesterone may influence eating disorders. Currently, whether these hormones play an organizational role in eating disorder risk is unclear.
Further, given the consistent evidence indicating increased risk and severity of ED pathology among sexual minority boys, treatment that specifically addresses a broad spectrum of gender and sexual presentations, including among those who identify as transgender or gender fluid, is necessary. Precision ED treatment of boys should directly address muscularity-oriented body image concerns, potentially minimizing exercise behavior that exacerbates and maintains these symptoms. In a nationally representative cohort of high school students in Norway, male adolescents with same-sex sexual experience were more likely to report bulimic symptoms than those buy testosterone online without prescription same-sex sexual experience (estimated 7 times the risk in males with same-sex sexual experience).53 Taken together, the extant research on models of ED and their intersection with sexual orientation suggest that sexual minority status may be a contributing risk factor for ED among young males. Among youth and adolescents seeking treatment of an ED, approximately 14% are diagnosed with ARFID and, compared with other EDs, a larger proportion of these cases, up to 35%, are boys.28–31 As ARFID is comparatively recent in its characterization as a pediatric ED, future research is needed to illuminate sex differences in symptom presentation, as well as treatment response. Review of the extant adult literature indicates that binge eating seems to be the most common ED behavior in males, with a prevalence nearly equivalent to that of females among adult samples based on DSM-IV criteria.4,7 Current DSM-5 diagnostic criteria for BED requires that objective binge eating episodes must occur with a minimum frequency of once per week for 3 months.19 These current criteria are a reduction in frequency from DSM-IV, which required twice weekly episodes, and thus it is reasonable to conclude that the number of men with BED is systematically increased with the advent of DSM-5.
Importantly, hormone augmentation alone is not an adequate treatment for an eating disorder, so this should be applied only in conjunction with additional forms of treatment, 121.43.244.209 such as cognitive–behavioral therapy – which is often the treatment of choice for eating disorders, specifically BN and BED. It is also suggested that aspects of puberty and eating disorder symptoms share genetic vulnerability factors. Comparing the genetic influences on eating disorder symptomatology in girls pre- and post-puberty indicates that the genetic effects for eating disorder symptomatology in prepubertal girls were near 0% but rose markedly to approximately 60% in postpubertal girls and young adults 74,75. However, to date, studies have not examined the separate phases of pregnancy to determine in which phase risk and remission typically occurs, or whether it is the hormone concentration or http://47.107.188.236:3000/mariahavelock0 flux in estradiol and progesterone that may serve as the critical window for risk or remission. It appears that the impact of pregnancy on eating disorder symptoms varies across women, representing a window of remission, relapse and new onset for BED.
That said, there are some indications that male BN, similar to male AN, presents with nuanced differences in symptom presentation. In the following sections, prevalence estimates, as well as factors that are both similar and divergent across the sexes in presentation of transdiagnostic EDs, are presented. The widespread screening efforts for thinness-oriented ED behaviors that support this cardinal feature (eg, caloric restriction) are largely due to researchers who must extrapolate ED symptoms from female samples. In the following discussion of this broad subject domain, current relevant evidence on EDs among males is synthesized, and clinical and theoretic implications are discussed along with critical directions for future research.